Biomarin Pharmaceutical (BMRN) Gross Profit (2009 - 2026)
Biomarin Pharmaceutical (BMRN) recorded Gross Profit of $786.91 million in Q2 2026, up 16.5% from $675.32 million a year earlier and up 37.8% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Gross Profit (2009 - 2026) Analysis & Trends
On a TTM basis, Biomarin Pharmaceutical's Gross Profit came in at $2.59 billion as of Jun 30, 2026, up 6.4% year-over-year; for FY2025, it came in at $2.5 billion, up 10.1% from FY2024.
- Annual Gross Profit has increased for five straight years, with a five-year compound annual growth rate of 13.4% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $2.27 billion in FY2024 (+20.5%), $1.89 billion in FY2023 (+18.5%), $1.59 billion in FY2022 (+15.8%) and $1.38 billion in FY2021 (+3.0%).
- The Q2 2026 figure is the highest quarterly Gross Profit in data going back to Q2 2009.
- On a year-over-year basis, Gross Profit rose in six of the last eight quarters, with growth averaging 12.2%.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 30.0% in Q4 2023, against a decline of 3.8% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $571.21 million (Q1 2026), $598.86 million (Q4 2025) and $636.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 786.91 Mn |
| Mar 31, 2026 | 571.21 Mn |
| Dec 31, 2025 | 598.86 Mn |
| Sep 30, 2025 | 636.05 Mn |
| Jun 30, 2025 | 675.32 Mn |
| Mar 31, 2025 | 593.59 Mn |
| Dec 31, 2024 | 611.17 Mn |
| Sep 30, 2024 | 557.28 Mn |
| Jun 30, 2024 | 581.57 Mn |
| Mar 31, 2024 | 523.65 Mn |
| Dec 31, 2023 | 508.28 Mn |
| Sep 30, 2023 | 453.29 Mn |
| Jun 30, 2023 | 464.66 Mn |
| Mar 31, 2023 | 460.94 Mn |
| Dec 31, 2022 | 390.89 Mn |
| Sep 30, 2022 | 389.06 Mn |
| Jun 30, 2022 | 410.67 Mn |
| Mar 31, 2022 | 402.39 Mn |
| Dec 31, 2021 | 330.06 Mn |
| Sep 30, 2021 | 305.21 Mn |
API Access
Biomarin Pharmaceutical Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();